Clenbuterol antagonizes glucocorticoid-induced atrophy and fibre type transformation in mice

Experimental Physiology

Volumn 89, Issue 1, 2004, Pages 89-100

  Pellegrino, Maria Antonietta ^a   D'Antona, Giuseppe ^a   Bortolotto, Susan ^b   Boschi, Federica ^a   Pastoris, Ornella ^a   Bottinelli, Roberto ^a   Polla, Biagio ^c   Reggiani, Carlo ^b  

^a UNIVERSITY OF PAVIA   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

^c Hospital S Biagio   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

6 PHOSPHOFRUCTOKINASE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CITRATE SYNTHASE; CLENBUTEROL; CYTOCHROME C OXIDASE; DEXAMETHASONE; DRINKING WATER; GLUCOCORTICOID; GLYCOLYTIC ENZYME; LACTATE DEHYDROGENASE; MITOCHONDRIAL ENZYME; MYOSIN HEAVY CHAIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTHMA; BREATHING MUSCLE; CELL TRANSFORMATION; CONTROLLED STUDY; DIAPHRAGM; DOSE RESPONSE; DRUG ANTAGONISM; ENZYME ACTIVITY; FAST MUSCLE; MALE; MOUSE; MUSCLE ATROPHY; MUSCLE CELL; MUSCLE MASS; NONHUMAN; PROTEIN LOCALIZATION; SKELETAL MUSCLE; SOLEUS MUSCLE; TIBIALIS ANTERIOR MUSCLE;

EID: 1642462916     PISSN: 09580670     EISSN: None     Source Type: Journal    
DOI: 10.1113/expphysiol.2003.002609     Document Type: Article

References (56)

1. Agbenyega ET & Wareham AC (1992). Effect of clenbuterol on skeletal muscle atrophy in mice induced by the glucocorticoid dexamethasone. Comp Biochem Physiol Comp Physiol 102, 141-145.
2. Andersen JL, Gruschy-Knudsen T, Sandri C, Larsson L & Schiaffino S (1999). Bed rest increases the amount of mismatched fibers in human skeletal muscle. J Appl Physiol 86, 455-460.
3. Awede BL, Thissen JP & Lebacq J (2002). Role of IGF-I and IGFBPs in the changes of mass and phenotype induced in rat soleus muscle by clenbuterol. Am J Physiol Endocrinol Metab 282, E31-E37.
4. Babij P & Booth FW (1988). Clenbuterol prevents or inhibits loss of specific mRNAs in atrophying rat skeletal muscle. Am J Physiol 254, C657-C660.
5. van Balkom RH, Dekhuijzen PN, van der Heijden HF, Folgering HT, Fransen JA & van Herwaarden CL (1999). Effects of anabolic steroids on diaphragm impairment induced by methylprednisolone in emphysematous hamsters. Eur Respir J 13, 1062-1069.
6. van Balkom RH, van der Heijden HF, van Moerkerk HT, Veerkamp JH, Fransen JA, Ginsel LA, Folgering HT, van Herwaarden CL & Dekhuijzen PN (1996). Effects of different treatment regimens of methylprednisolone on rat diaphragm contractility, immunohistochemistry and biochemistry. Eur Respir J 9, 1217-1223.
7. Bodine SC, Latres E, Baumhueter S, Lai VK, Nunez L, Clarke BA, Poueymirou WT, Panaro FJ, Na E, Dharmarajan K, Pan ZQ, Valenzuela DM, DeChiara TM, Stitt TN, Yancopoulos GD & Glass DJ (2001). Identification of ubiquitin ligases required for skeletal muscle atrophy. Science 294, 1704-1708.
8. Bottinelli R, Schiaffino S & Reggiani C (1991). Force-velocity relations and myosin heavy chain isoform compositions of skinned fibres from rat skeletal muscle. J Physiol 437, 655-672.
9. Bowyer SL, LaMothe MP & Hollister JR (1985). Steroid myopathy: incidence and detection in a population with asthma. J Allergy Clin Immunol 76, 234-242.
10. Caiozzo VJ, Baker MJ & Baldwin KM (1998). Novel transitions in MHC isoforms: separate and combined effects of thyroid hormone and mechanical unloading. J Appl Physiol 85, 2237-2248.
11. D'Antona G, Pellegrino MA, Adami R, Rossi R, Naccari-Carlizzi C, Canepari M, Saltin B & Bottinelli R (2003). The effect of ageing and immobilization on structure and function of human skeletal muscle fibres. J Physiol 552, 499-511.
12. D'Antona G, Pellegrino MA, Rossi R, Naccari Carlizzi C, Reggiani C & Bottinelli R (2000). Disuse induced-atrophy and contractile impairment of human skeletal muscle fibres. Basic Appl Myol 10, 27-32.
13. Davies AO & Lefkowitz RJ (1984). Regulation of beta-adrenergic receptors by steroid hormones. Annu Rev Physiol 46, 119-130.
14. Dong Y, Aronsson M, Gustafsson JA & Okret S (1989). The mechanism of cAMP-induced glucocorticoid receptor expression. Correlation to cellular glucocorticoid response. J Biol Chem 264, 13679-13683.
15. Dupont-Versteegden EE, Katz MS & McCarter RJ (1995). Beneficial versus adverse effects of long-term use of clenbuterol in mdx mice. Muscle Nerve 18, 1447-1459.
16. Erzen I, Primc M, Janmot C, Cvetko E, Sketelj J & d'Albis A (1999). Myosin heavy chain profiles in regenerated fast and slow muscles innervated by the same motor nerve become nearly identical. Histochem 131, 277-283.
17. Gardiner PF & Edgerton VR (1979). Contractile responses of rat fast-twitch and slow-twitch muscles to glucocorticoid treatment. Muscle Nerve 2, 274-281.
18. Hayes A & Williams DA (1997). Contractile properties of clenbuterol-treated mdx muscle are enhanced by low-intensity swimming. J Appl Physiol 82, 435-439.
19. Hickson RC & Davis JR (1981). Partial prevention of glucocorticoid-induced muscle atrophy by endurance training. Am J Physiol 241, E226-E232.
20. Hinkle RT, Hodge KM, Cody DB, Sheldon RJ, Kobilka BK & Isfort RJ (2002). Skeletal muscle hypertrophy and anti-atrophy effects of clenbuterol are mediated by the beta2-adrenergic receptor. Muscle Nerve 25, 729-734.
21. Huang H, Gazzola C, Pegg GG & Sillence MN (2000). Differential effects of dexamethasone and clenbuterol on rat growth and on beta2-adrenoceptors in lung and skeletal muscle. J Anim Sci 78, 604-608.
22. Jansen S & Decramer M (1989). Corticosteroid induced myopathy and respiratory muscles. Chest 95, 1160-1162.
23. Jiang TX, Cairns A, Road JD & Wilcox PG (1996). Effect of the beta-agonist clenbuterol on dexamethasone-induced diaphragm dysfunction in rabbits. Am J Respir Crit Care Med 154, 1778-1783.
24. Kanda F, Takatani K, Okuda S, Matsushita T & Chihara K (1999). Preventive effects of insulinlike growth factor-I on steroid-induced muscle atrophy. Muscle Nerve 22, 213-217.
25. Laemmli U.K. (1970). Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680-685.
26. Lewis MI, Monn SA & Sieck GC (1992). Effect of corticosteroids on diaphragm fatigue, SDH activity, and muscle fiber size. J Appl Physiol 72, 293-301.
27. Lieu FK, Powers SK, Herb RA, Criswell D, Martin D, Wood C, Stainsby W & Chen CL (1993). Exercise and glucocorticoid-induced diaphragmatic myopathy. J Appl Physiol 75, 763-771.
28. Lynch GS, Hayes A, Campbell SP & Williams DA (1996). Effects of beta 2-agonist administration and exercise on contractile activation of skeletal muscle fibers. J Appl Physiol 81, 1610-1618.
29. Mak JC, Nishikawa M & Barnes PJ (1995a). Glucocorticosteroids increase beta 2-adrenergic receptor transcription in human lung. Am J Physiol 268, L41-L46.
30. Mak JC, Nishikawa M, Shirasaki H, Miyayasu K & Barnes PJ (1995b). Protective effects of a glucocorticoid on downregulation of pulmonary beta 2-adrenergic receptors in vivo. J Clin Invest 96, 99-106.
31. Marinovic AC, Zheng B, Mitch WE & Price SR (2002). Ubiquitin (UbC) expression in muscle cells is increased by glucocorticoids through a mechanism involving Sp1 and MEK1. J Biol Chem 277, 16673-16681.
32. Martens ME, Peterson PL & Lee CP (1991). In vitro effects of glucocorticoid on mitochondrial energy metabolism. Biochim Biophys Acta 1058, 152-160.
33. Martin WH, 3rd Murphree SS & Saffitz JE (1989). Beta-adrenergic receptor distribution among muscle fiber types and resistance arterioles of white, red, and intermediate skeletal muscle. Circ Res 64, 1096-1105.
34. Mitsui T, Umaki Y, Nagasawa M, Akaike M, Aki K, Azuma H, Ozaki S, Odomi M & Matsumoto T (2002). Mitochondrial damage in patients with long-term corticosteroid therapy: development of oculoskeletal symptoms similar to mitochondrial disease. Acta Neuropathol (Berl) 104, 260-266.
35. Navegantes LC, Resano NM, Migliorini RH & Kettelhut IC (2001). Catecholamines inhibit Ca (2+) -dependent proteolysis in rat skeletal muscle through beta (2) -adrenoceptors and cAMP. Am J Physiol Endocrinol Metab 281, E449-E454.
36. NIHLBI/WHO Workshop Report. (2002). Global Strategy for Asthma Management and Prevention, pp. 118-132. National Institute of Health. National Heart, Lung, and. Blood Institute, Bethesda, MD.
37. Oddera S, Silvestri M, Testi R & Rossi GA (1998). Salmeterol enhances the inhibitory activity of dexamethasone on allergen-induced blood mononuclear cell activation. Respiration 65, 199-204.
38. Pang L & Knox AJ (2000). Synergistic inhibition by beta (2) -agonists and corticosteroids on tumor necrosis factor-alpha-induced interleukin-8 release from cultured human airway smooth-muscle cells. Am J Respir Cell Mol Biol 23, 79-85.
39. Pellegrino MA, Canepari M, Rossi R, D'Antona G, Reggiani C & Bottinelli R (2003). Orthologous myosin isoforms and scaling of shortening velocity with body size in mouse, rat, rabbit and human muscles. J Physiol 546, 677-689.
40. Peters MJ, Adcock IM, Brown CR & Barnes PJ (1995). Beta-adrenoceptor agonists interfere with glucocorticoid receptor DNA binding in rat lung. Eur J Pharmacol 289, 275-281.
41. Pette D & Staron RS (1990). Cellular and molecular diversities of mammalian skeletal muscle fibers. Rev Physiol Biochem Pharmacol 116, 1-76.
42. Pette D & Staron RS (1997). Mammalian skeletal muscle fiber type transitions. Int Rev Cytol 170, 143-223.
43. Polla B, Bottinelli R, Sandoli D, Sardi C & Reggiani C (1994). Cortisone-induced changes in myosin heavy chain distribution in respiratory and hindlimb muscles. Acta Physiol Scand 151, 353-361.
44. Polla B, Cappelli V, Morello F, Pellegrino MA, Boschi F, Pastoris O & Reggiani C (2001). Effects of the beta (2) -agonist clenbuterol on respiratory and limb muscles of weaning rats. Am J Physiol Regul Integr Comp Physiol 280, R862-R869.
45. Schiaffino S & Reggiani C (1996). Molecular diversity of myofibrillar proteins: gene regulation and functional significance. Physiol Rev 76, 371-423.
46. Shah OJ, Iniguez-Lluhi JA, Romanelli A, Kimball SR & Jefferson LS (2002). The activated glucocorticoid receptor modulates presumptive autoregulation of ribosomal protein S6 protein kinase, p70 S6K. J Biol Chem 277, 2525-2533.
47. Simon N, Jolliet P, Morin C, Zini R, Urien S & Tillement JP (1998). Glucocorticoids decrease cytochrome c oxidase activity of isolated rat kidney mitochondria. FEBS Lett 435, 25-28.
48. Sneddon AA, Delday MI, Steven J & Maltin CA (2001). Elevated IGF-II mRNA and phosphorylation of 4E-BP1 and p70 (S6k) in muscle showing clenbuterol-induced anabolism. Am J Physiol Endocrinol Metab 281, E676-E682.
49. Stevens DA, Barnes PJ & Adcock IM (1995). Beta agonists inhibit DNA binding of glucocorticoid responses in human activity in human lung. Am J Resp Crit Care Med 151, A195.
50. Talmadge RJ & Roy RR (1993). Electrophoretic separation of rat skeletal muscle myosin heavy-chain isoforms. J Appl Physiol 75, 2337-2340.
51. Talmadge RJ, Roy RR & Edgerton VR (1996). Distribution of myosin heavy chain isoforms in non-weight-bearing rat soleus muscle fibers. J Appl Physiol 81, 2540-2546.
52. Taylor DR & Hancox RJ (2000). Interactions between corticosteroids and beta agonists. Thorax 55, 595-602.
53. Williams RS, Caron MG & Daniel K (1984). Skeletal muscle beta-adrenergic receptors: variations due to fiber type and training. Am J Physiol 246, E160-E167.
54. Zeman RJ, Ludemann R, Easton TG & Etlinger JD (1988). Slow to fast alterations in skeletal muscle fibers caused by clenbuterol, a beta 2-receptor agonist. Am J Physiol 254, E726-E732.
55. Zeman RJ, Ludemann R & Etlinger JD (1987). Clenbuterol, a beta 2-agonist, retards atrophy in denervated muscles. Am J Physiol 252, E152-E155.
56. Zeman RJ, Zhang Y & Etlinger JD (1994). Clenbuterol, a beta 2-agonist, retards wasting and loss of contractility in irradiated dystrophic mdx muscle. Am J Physiol 267, C865-C868.